| Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial R Rosenheck, D Perlick, S Bingham, W Liu-Mares, J Collins, S Warren, ... Jama 290 (20), 2693-2702, 2003 | 474 | 2003 |
| Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. M Davidson, PD Harvey, P Powchik, M Parrella, L White, HY Knobler, ... The American journal of psychiatry 152 (2), 197-207, 1995 | 415 | 1995 |
| The therapeutic potentials of ayahuasca: possible effects against various diseases of civilization E Frecska, P Bokor, M Winkelman Frontiers in pharmacology 7, 35, 2016 | 366 | 2016 |
| Ventricular enlargement in poor-outcome schizophrenia KL Davis, MS Buchsbaum, L Shihabuddin, J Spiegel-Cohen, M Metzger, ... Biological psychiatry 43 (11), 783-793, 1998 | 275 | 1998 |
| Psychedelic N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte … A Szabo, A Kovacs, E Frecska, E Rajnavolgyi PloS one 9 (8), e106533, 2014 | 218 | 2014 |
| A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity E Frecska, A Szabo, MJ Winkelman, LE Luna, DJ McKenna Journal of neural transmission 120, 1295-1303, 2013 | 158 | 2013 |
| The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases B Penke, L Fulop, M Szucs, E Frecska Current Neuropharmacology 16 (1), 97-116, 2018 | 145 | 2018 |
| The endogenous hallucinogen and trace amine N, N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary … A Szabo, A Kovacs, J Riba, S Djurovic, E Rajnavolgyi, E Frecska Frontiers in neuroscience 10, 423, 2016 | 130 | 2016 |
| Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification ND Volkow, GJ Wang, JE Overall, R Hitzemann, JS Fowler, N Pappas, ... Alcoholism: Clinical and Experimental Research 21 (7), 1278-1284, 1997 | 124 | 1997 |
| Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies E Frecska, CE Móré, A Vargha, LE Luna Journal of psychoactive drugs 44 (3), 191-199, 2012 | 122 | 2012 |
| Social bonding in the modulation of the physiology of ritual trance E Frecska, Z Kulcsar Ethos 17 (1), 70-87, 1989 | 105 | 1989 |
| Digit length pattern in schizophrenia suggests disturbed prenatal hemispheric lateralization M Arató, E Frecska, C Beck, M An, H Kiss Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (1), 191-194, 2004 | 98 | 2004 |
| Inner paths to outer space: Journeys to alien worlds through psychedelics and other spiritual technologies R Strassman, S Wojtowicz, LE Luna, E Frecska Simon and Schuster, 2008 | 94 | 2008 |
| Serotonergic interhemispheric asymmetry: gender difference in the orbital cortex M Arató, E Frecska, K Tekes, DJ MacCrimmon Acta Psychiatrica Scandinavica 84 (1), 110-111, 1991 | 84 | 1991 |
| Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence M Arato, E Frecska, DJ MacCrimmon, R Guscott, B Saxena, K Tekes, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 15 (6), 759-764, 1991 | 82 | 1991 |
| Composition for the treatment of schizophrenia A Perenyi, G Utpal, M Arato, E Frescka, J Knoll, DA Bela US Patent 5,151,419, 1992 | 71 | 1992 |
| N, N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats S Nardai, M László, A Szabó, A Alpár, J Hanics, P Zahola, B Merkely, ... Experimental Neurology 327, 113245, 2020 | 64 | 2020 |
| Reversed hemispheric asymmetry of imipramine binding in suicide victims M Arató, K Tekes, L Tóthfalusi, K Magyar, M Palkovits, E Frecska, A Falus, ... Biological psychiatry 29 (7), 699-702, 1991 | 60 | 1991 |
| Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation E Frecska, KD White, LE Luna Psychopharmacology 173, 79-87, 2004 | 57 | 2004 |
| N, N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain Í Szabó, VÉ Varga, S Dvorácskó, AE Farkas, T Körmöczi, R Berkecz, ... Neuropharmacology 192, 108612, 2021 | 54 | 2021 |